Iterum Therapeutics plc
ITRM
$0.9966
-$0.0534-5.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.77M | -30.55M | -28.34M | -35.58M | -38.37M |
| Total Depreciation and Amortization | 284.00K | 463.00K | 891.00K | 1.32M | 1.75M |
| Total Amortization of Deferred Charges | 2.29M | 4.28M | 2.32M | 2.33M | 2.34M |
| Total Other Non-Cash Items | 8.16M | 4.06M | -9.22M | -8.62M | -7.81M |
| Change in Net Operating Assets | -12.73M | -13.61M | -7.60M | -2.28M | 2.76M |
| Cash from Operations | -26.77M | -35.36M | -41.95M | -42.82M | -39.33M |
| Capital Expenditure | -2.00K | -2.00K | 1.00K | -13.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.21M | 30.63M | 25.29M | 25.45M | 23.35M |
| Cash from Investing | 18.21M | 30.63M | 25.29M | 25.44M | 23.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.69M | 13.40M | 7.98M | 8.02M | 1.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.69M | 13.40M | 7.98M | 8.02M | 1.03M |
| Foreign Exchange rate Adjustments | -75.00K | -87.00K | -82.00K | -76.00K | -61.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.05M | 8.59M | -8.76M | -9.44M | -15.02M |